Advertisement

Topics

Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla

00:07 EDT 27 Jul 2017 | Drugs.com

PRINCETON, N.J., July 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women's healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's New Drug...

Original Article: Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla

NEXT ARTICLE

More From BioPortfolio on "Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla"

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...